|
1
|
Olsen MH, Angell SY, Asma S, Boutouyrie P,
Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo AP,
Hering D, et al: A call to action and a lifecourse strategy to
address the global burden of raised blood pressure on current and
future generations: The lancet commission on hypertension. Lancet.
388:2665–2712. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ettehad D, Emdin CA, Kiran A, Anderson SG,
Callender T, Emberson J, Chalmers J, Rodgers A and Rahimi K: Blood
pressure lowering for prevention of cardiovascular disease and
death: A systematic review and meta-analysis. Lancet. 387:957–967.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vriz O, Magne J, Jarosh J, Bossone E,
Aboyans V and Palatini P: Local carotid arterial stiffness is an
independent determinant of left ventricular remodeling in
never-treated hypertensive patients. Blood Press. 28:23–33.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Johnson RD and Camelliti P: Role of
non-myocyte gap junctions and connexin hemichannels in
cardiovascular health and disease: Novel therapeutic targets? Int J
Mol Sci. 19(866)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Desai CS, Ning H and Lloyd-Jones DM:
Competing cardiovascular outcomes associated with
electrocardiographic left ventricular hypertrophy: The
atherosclerosis risk in communities study. Heart. 98:330–334.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Opie LH, Commerford PJ, Gersh BJ and
Pfeffer MA: Controversies in ventricular remodeling. Lancet.
367:356–367. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Camargo LL, Harvey AP, Rios FJ,
Tsiropoulou S, Da Silva RNO, Cao Z, Graham D, McMaster C, Burchmore
RJ, Hartley RC, et al: Vascular Nox (NADPH oxidase)
compartmentalization, protein hyperoxidation, and endoplasmic
reticulum stress response in hypertension. Hypertension.
72:235–246. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schaffer AL, Buckley NA and Pearson SA:
Who benefits from fixed-dose combinations? Two-year statin
adherence trajectories in initiators of combined
amlodipine/atorvastatin therapy. Pharmacoepidemiol Drug Saf.
26:1465–1473. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Chen HJ, Yao L, Chen TG, Yu M, Wang LH and
Chen JZ: Atorvastatin prevents connexin43 remodeling in
hypertrophied left ventricular myocardium of spontaneously
hypertensive rats. Chin Med J (Engl). 120:1902–1907.
2007.PubMed/NCBI
|
|
10
|
Waters D, Higginson L, Gladstone P,
Kimball B, Le May M, Boccuzzi SJ and Lespérance J: Effects of
monotherapy with an HMG-CoA reductase inhibitor on the progression
of coronary atherosclerosis as assessed by serial quantitative
arteriography. The Canadian coronary atherosclerosis treatment
trial. Circulation. 3:959–968. 1994.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Salameh A: Life cycle of connexins:
Regulation of connexin synthesis and degradation. Adv Cardiol.
42:57–70. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Söhl G and Willecke K: Gap junctions and
the connexin protein family. Cardiovasc Res. 62:228–232.
2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rodriguez-Sinovas A: Cx43 phosphorylation
and cardioprotection. Cardiovasc Res. 83:613–614. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Egan Benova T, Szeiffova Bacova B,
Viczenczova C, Diez E, Barancik M and Tribulova N: Protection of
cardiac cell-to-cell coupling attenuate myocardial remodeling and
proarrhythmia induced by hypertension. Physiol Res. 65 (Suppl
1):S29–S42. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheng G, Chen CY, Shou XL and Han XY:
Effects of captopril on the expression of connexin 43 in thoracic
aorta from spontaneous hypertensive rats. J Shaanxi Med.
44:1571–1573. 2015.
|
|
16
|
Martins-Marques T, Catarino S, Marques C,
Matafome P, Ribeiro-Rodrigues T, Baptista R, Pereira P and Girão H:
Heart ischemia results in connexin43 ubiquitination localized at
the intercalated discs. Biochimie. 112:196–201. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Martins-Marques T, Catarino S, Zuzarte M,
Marques C, Matafome P, Pereira P and Girão H: Ischaemia-induced
autophagy leads to degradation of gap junction protein connexin43
in cardiomyocytes. Biochem J. 467:231–245. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xue J, Yan X, Yang Y, Chen M, Wu L, Gou Z,
Sun Z, Talabieke S, Zheng Y and Luo D: Connexin 43
dephosphorylation contributes to arrhythmias and cardiomyocyte
apoptosis in ischemia/reperfusion hearts. Basic Res Cardiol.
114(40)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hradec J, Zamorano J and Sutradhar S: Post
hoc analysis of the cluster randomized usual care versus caduet
investigation assessing long-term risk (CRUCIAL) trial. Curr Med
Res Opin. 29:589–596. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lu J, Liu F, Chen F, Jin Y, Chen H, Liu D
and Cui W: Amlodipine and atorvastatin improve ventricular
hypertrophy and diastolic function via inhibiting TNF-α, IL-1β and
NF-κB inflammatory cytokine networks in elderly spontaneously
hypertensive rats. Biomed Pharmacother. 83:330–339. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang ZY, Li Y, Li R, Zhang AA, Shang B,
Yu J and Xie XD: Tetrahydrobiopterin protects against
radiation-induced growth inhibition in H9c2 cardiomyocytes. Chin
Med J (Engl). 129:2733–2740. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jin Y, Jing M, Zhang L, Song S and Ma X:
Internet access and hypertension management among the elderly
population: A nationally representative cross-sectional survey in
China. J Med Internet Res. 31(e11280)2019.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Kearney PM, Whelton M, Reynolds K, Muntner
P, Whelton PK and He J: Global burden of hypertension: Analysis of
worldwide data. Lancet. 365:217–223. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Delvaeye T, Vandenabeele P, Bultynck G,
Leybaert L and Krysko DV: Therapeutic targeting of connexin
channels: New views and challenges. Trends Mol Med. 24:1036–1053.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nagasawa K, Takahashi K, Matsuura N,
Takatsu M, Hattori T, Watanabe S, Harada E, Niinuma K, Murohara T
and Nagata K: Comparative effects of valsartan combination with
cilnidipine or amlodipine on cardiac remodeling and diastolic
dysfunction in Dahl salt-sensitive rats. Hypertens Res. 38:39–47.
2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen Y, Chang Y, Zhang N, Guo X, Sun G and
Sun Y: Atorvastatin attenuates myocardial hypertrophy in
spontaneously hypertensive rats via the C/EBPβ/PGC-1α/UCP pathway.
Cell Physiol Biochem. 46:1009–1018. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Naydenov Naydenov S, Margaritov Runev N,
Ivanov Manov E and Georgieva Torbova-Gigova S: Efficacy and safety
of a single-pill combination of atorvastatin/amlodipine in patients
with arterial hypertension and dyslipidemia. Acta Clin Croat.
57:464–472. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Song D, Liu X, Liu R, Yang L, Zuo J and
Liu W: Connexin 43 hemichannel regulates H9c2 cell proliferation by
modulating intracellular ATP and [Ca2+]. Acta Biochim Biophys Sin
(Shanghai). 42:472–482. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Seki A, Nishii K and Hagiwara N: Gap
junctional regulation of pressure, fluid force, and electrical
fields in the epigenetics of cardiac morphogenesis and remodeling.
Life Sci. 129:27–34. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhai H, Dai W and Wang Y: Metoprolol
protects cardiomyocytes in rabbit model of heart failure by
regulating Cx43. Exp Ther Med. 15:1902–1905. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nao T, Ohkusa T, Hisamatsu Y, Inoue N,
Matsumoto T, Yamada J, Shimizu A, Yoshiga Y, Yamagata T, Kobayashi
S, et al: Comparison of expression of connexin in right atrial
myocardium in patients with chronic atrial fibrillation versus
those in sinus rhythm. Am J Cardiol. 91:678–683. 2003.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xing D, Kjølbye AL, Nielsen MS, Petersen
JS, Harlow KW, Holstein-Rathlou NH and Martins JB: ZP123 increases
gap junctional conductance and prevents reentrant ventricular
tachycardia during myocardial ischemia in open chest dogs. J
Cardiovasc Electrophysiol. 14:510–520. 2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang LJ, Ma KT, Shi WY, Wang YZ, Zhao L,
Chen XY, Li XZ, Jiang XW, Zhang ZS, Li L and Si JQ: Enhance gap
junction channel activity between vascular smooth muscle cells in
cerebral artery of spontaneously hypertensive rats. Clin Exp
Hypertens. 39:295–305. 2017.PubMed/NCBI View Article : Google Scholar
|
